These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4265782)

  • 21. Observations on the plasma kallikreinogen (prekallikrein)-kallikrein enzyme system.
    Sherry S; Colman RW
    Trans Assoc Am Physicians; 1968; 81():40-8. PubMed ID: 5305252
    [No Abstract]   [Full Text] [Related]  

  • 22. [Study of the enzymes and substrates of the kallikrein-kinin system in the blood of patients with chronic tonsillitis before and after tonsillectomy].
    Beremeenko KN; Lositskaia VM; Zrazhva EL
    Vestn Otorinolaringol; 1974; 0(6):45-9. PubMed ID: 4432308
    [No Abstract]   [Full Text] [Related]  

  • 23. [The effect of protease tissue inhibitor on the activity of pancreatic proteolytic enzymes in in-vitro experiments].
    Egorova EF; Chernoiarova OD; Ryzhkova GI
    Eksp Klin Farmakol; 1992; 55(3):39-41. PubMed ID: 1458161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A quick photometric method for the determination of activable plasminogen and of plasmin].
    Bouvier CA; Berthoud S; Roth M
    Thromb Diath Haemorrh; 1967 May; 17(3-4):452-66. PubMed ID: 4231950
    [No Abstract]   [Full Text] [Related]  

  • 25. Separation of kinin-forming factors in human plasma.
    Eisen V; Glanville KL
    Br J Exp Pathol; 1969 Oct; 50(5):427-37. PubMed ID: 5348003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [THE COMBINED EFFECT OF FIBRINOLYSIS INHIBITORS].
    MARKWARDT F; KLOECKING HP; RICHTER M
    Acta Biol Med Ger; 1964; 12():522-4. PubMed ID: 14134957
    [No Abstract]   [Full Text] [Related]  

  • 27. Kinetic characterization of heparin-catalyzed and uncatalyzed inhibition of blood coagulation proteinases by antithrombin.
    Olson ST; Björk I; Shore JD
    Methods Enzymol; 1993; 222():525-59. PubMed ID: 8412815
    [No Abstract]   [Full Text] [Related]  

  • 28. Amidino-substituted aromatic heterocycles as probes of the specificity pocket of trypsin-like proteases.
    Geratz JD; Stevens FM; Polakoski KL; Parrish RF; Tidwell RR
    Arch Biochem Biophys; 1979 Oct; 197(2):551-9. PubMed ID: 41488
    [No Abstract]   [Full Text] [Related]  

  • 29. Defective esterase and kinin-forming activity in human Fletcher trait plasma. A fraction rich in kallikreinlike activity.
    Donaldson VH; Saito H; Ratnoff OD
    Circ Res; 1974 May; 34(5):652-62. PubMed ID: 4545268
    [No Abstract]   [Full Text] [Related]  

  • 30. Studies of kallikrein inhibitors in potatoes. II. Effect of potato kallikrein inhibitors on various kallikreins and other proteases.
    Hojima Y; Moriya H; Moriwaki C
    J Biochem; 1971 Jun; 69(6):1027-32. PubMed ID: 4253726
    [No Abstract]   [Full Text] [Related]  

  • 31. The activity of plasma, serum, thrombin, and plasmin toward synthetic trypsin substrates.
    Szczeklik E; Orlowski M; Szczeklik A; Narczewska B
    Thromb Diath Haemorrh; 1968 Mar; 19(1):99-106. PubMed ID: 4231461
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of covalent binding of aprotinin with a polysaccharide carrier on its inhibition of kallikrein from human plasma, porcine pancreatic kallikrein and trypsin].
    Larionova NI; Makevnina LG; Nartikova VF; Paskhina TS
    Biokhimiia; 1987 May; 52(5):825-31. PubMed ID: 2439135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Further evidence for an active center in streptokinase-plasminogen complex; interaction with pancreatic trypsin inhibitor.
    Reddy KN; Markus G
    Biochem Biophys Res Commun; 1973 Apr; 51(3):672-9. PubMed ID: 4267404
    [No Abstract]   [Full Text] [Related]  

  • 34. ENZYMATIC AND PHYSIOLOGICAL STUDIES ON THE PROTEASES HETEROGENOUS TO THE BODY. I. SUBSTRATE SPECIFICITY, INHIBITORS, AND THE PHYSIOLOGICAL FATE OF ASPERKINASE.
    OSHIBA S; MIHARA H; HATA S; OKAMOTO S
    Kobe J Med Sci; 1963 Dec; 18():139-49. PubMed ID: 14160534
    [No Abstract]   [Full Text] [Related]  

  • 35. [THE TREATMENT OF THROMBOSES BY LOCAL INFUSION OF FIBRINOLYTIC ENZYMES].
    BENZER H; BLUEMEL G; GOTTLOB R; PIZA F
    Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1963 Nov; 304():775-80. PubMed ID: 14120202
    [No Abstract]   [Full Text] [Related]  

  • 36. Human plasma kallikreins and their inhibition by amidino compounds.
    Asghar SS; Meijlink FC; Pondman KW; Cormane RH
    Biochim Biophys Acta; 1976 Jun; 438(1):250-64. PubMed ID: 1084762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Some properties of thermolabile trypsin, plasmin and kallikrein inhibitor from rabbit blood serum].
    Paskhina TS; Shimonaeva EE
    Vopr Med Khim; 1967; 13(5):464-71. PubMed ID: 4235108
    [No Abstract]   [Full Text] [Related]  

  • 38. [Purification and characteristics of an acid-resistant inhibitor of trypsin from rabbit blood serum].
    Nartikova VF; Paskhina TS
    Biokhimiia; 1969; 34(2):282-92. PubMed ID: 5802070
    [No Abstract]   [Full Text] [Related]  

  • 39. THE EUGLOBULIN METHOD FOR ESTIMATION OF FIBRINOLYTIC ACTIVITY IN UROKINASE-ACTIVATED PLASMA, AND THE INFLUENCE OF TRASYLOL.
    BLIX S
    Scand J Clin Lab Invest; 1964; 16():198-200. PubMed ID: 14161857
    [No Abstract]   [Full Text] [Related]  

  • 40. [The content and activity of basic components of kinin system in blood serum of patients with rheumatism].
    Paskhina TS; Iarovaia GA; Laufer AL; Gulikova OM; Trapeznikova SS; Morozova NA; Makarova OV; Tikhomirov IB; Sysoev VF; Mach ES
    Vopr Med Khim; 1970; 16(2):152-61. PubMed ID: 5311053
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.